# Exagen Inc. (XGN): MoatMap facts

As of 29 Oct 2026. Research data, not investment advice.

As of 29 Oct 2026, MoatMap's StockRank for Exagen Inc. (XGN) is 34/100, ranked against 24,000+ stocks in 35 markets (Quality 35, Value 26, Momentum 61, each scored against its sector).

- StockRank: 34/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 35, Value 26, Momentum 61: each a 0-100 percentile within Healthcare.
- Position: #17,558 overall, #1,523 in Healthcare.
- Listing: United States, NGM; Healthcare / Diagnostics & Research.
- Last close: 8.4 USD on 28 Oct 2026.
- Insider filings, last 180 days: directors sold USD 419K; 5%+ holders bought USD 104K.

Source: https://moatmap.ai/stock/XGN
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker